Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229–263

Article  PubMed  Google Scholar 

Mattiuzzi C, Sanchis-Gomar F, Lippi G (2019) Concise update on colorectal cancer epidemiology. Ann Transl Med 7(21):609

Article  PubMed  PubMed Central  Google Scholar 

Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A (2023) Colorectal cancer statistics. Cancer J Clin 73(3):233–254

Article  Google Scholar 

Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics. Cancer J Clin 74(1):12–49

Article  Google Scholar 

Rottoli M, Gori A, Pellino G, Flacco ME, Martellucci C, Spinelli A, Poggioli G, COVID–Colorectal Cancer (CRC) Study Group (2022) Colorectal cancer stage at diagnosis before vs during the COVID-19 pandemic in Italy. JAMA Netw Open 5(11):e2243119

Article  Google Scholar 

Chen H, Zhou S, Bi J et al (2021) Does the primary tumour location affect the prognosis of patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? World J Surg Oncol 19(1):253

Article  PubMed  PubMed Central  Google Scholar 

Hübner M, van Der Speeten K, Govaerts K et al (2024) 2022 peritoneal surface oncology group international consensus on HIPEC regimens for peritoneal malignancies: colorectal cancer. Ann Surg Oncol 31(1):567–576

Article  PubMed  Google Scholar 

Quenet F, Elias D, Roca L et al (2021) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22(2):256–266

Article  CAS  PubMed  Google Scholar 

Goeré D, Malka D, Tzanis D et al (2013) Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complte cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 257(6):1065–1071

Article  PubMed  Google Scholar 

Wang CB, Shahjehan F, Merchea A et al (2019) Impact of tumor location and variables associated with overall survival in patients with colorectal cancer: a mayo clinic colon and rectal cancer registry study. Front Oncol 9:76

Article  PubMed  PubMed Central  Google Scholar 

Violante T, Ferrari D, Day CN et al (2024) The effect of the pandemic on colorectal cancer in the United States: an increased disease burden. Surg Oncol Insight 1(1):100014

Article  Google Scholar 

Pędziwiatr M, Pisarska M, Kisielewski M et al (2016) ERAS protocol in laparoscopic surgery for colonic versus rectal carcinoma: are there differences in short-term outcomes? Med Oncol Northwood Lond Engl 33(6):56

Article  Google Scholar 

Simkens GA, van Oudheusden TR, Braam HJ et al (2016) Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control study. J Surg Oncol 113(5):548–553

Article  PubMed  Google Scholar 

Yu HH, Hsieh MC, Su BC (2022) Comparison of survival outcomes using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colon versus rectal cancer with peritoneal carcinomatosis in an Asian medical center. J Cancer Res Pract 9(2):59

Article  Google Scholar 

Kelly KJ, Alsayadnasser M, Vaida F et al (2019) Does primary tumor side matter in patients with metastatic colon cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? Ann Surg Oncol 26(5):1421–1427

Article  PubMed  Google Scholar 

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453–1457

Article  Google Scholar 

Stuart EA (2010) Matching methods for causal inference: a review and a look forward. Stat Sci 25(1):1–21

Article  PubMed  PubMed Central  Google Scholar 

Benvenisti H, Shiber M, Assaf D et al (2023) Perioperative and Oncological outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of rectal origin. J Gastrointest Surg 27:2506–2514

Article  PubMed  Google Scholar 

Conroy T, Etienne PL, Rio E et al (2023) Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial. J Clin Oncol 41:LBA3504

Article  Google Scholar 

Bahadoer RR, Dijkstra EA, van Etten B et al (2021) Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol 22:29–42

Article  CAS  PubMed  Google Scholar 

Jin J, Tang Y, Hu C et al (2022) Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol 40:1681–1692

Article  CAS  PubMed  PubMed Central  Google Scholar 

Passardi A, Canale M, Valgiusti M et al (2017) Immune checkpoints as a target for colorectal cancer treatment. Int J Mol Sci 18:1324

Article  PubMed  PubMed Central  Google Scholar